skip to content

Cambridge Academy of Therapeutic Sciences

 

The following projects have been selected for the AstraZeneca Funded Non-Clinical PhD Studentships starting 2025. If you are a prospective student please look at the adverts provided below.

UCAM-Supervisor                               

UCAM Department                                               

AZ-Supervisor                        Project Title                                                                                  
Prof. David Bulmer 
Pharmacology Fraser Welsh How does the microbiota contribute to chronic pain
Prof. David Spring Chemistry Jonathan Bargh Developing the next generation of antibody-oligonucleotide conjugates using divinylpyridimidine conjugation
Prof. Emma Rawlins Gurdon/PDN Luigi Aloia A reproducible human lung organoid platform for large scale oncology CRISPR screens
Prof. Ferdia Gallagher Radiology Richard Goodwin Multimodal and multiscale imaging: interrogating renal morphology and function across the disease landscape
Prof. Hugh Robinson Physiology, Development and Neuroscience (PDN) Philipe Mendonca Uncovering the electrophysiological fingerprints of neuroendocrine cancer cells
Prof. Laura Torrente-Murciano Chemical Engineering & Biotechnology Will Goundry Accelerating big data in material crystallization
Prof. Matthew Gaunt Chemistry Henry Blackwell Rapid development of new catalytic synthetic methodology for fragment-based drug discovery enabled by high-throughput experimentation
Prof. Ravindra Gupta Medicine Daniele Corridoni Interaction between innate immune activation and cell cycle status in macrophages: implications for inflammatory diseases
Prof. Roisin Owens Chemical Engineering and Biotechnology Muireann Coen Conformal electronic devices for non-invasive, dynamic monitoring of barrier tissues
Prof. Samuel Lambert Victor Phillip Dahdaleh Heart and Lung Research Institute, Department of Public Health & Primary Care Xiao Jiang Partitioning the effects of high body mass index on risk of future comorbidities.
Prof. Walid Khaled Pharmacology/ Cambridge Stem Cell Institute Mark Albertella

Therapeutic cancer prevention of hereditary cancers